Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availability

被引:9
|
作者
Esteban-Vasallo, Maria D. [1 ]
Felicitas Dominguez-Berjon, M. [1 ]
Gil de Miguel, Angel [2 ]
Astray-Mochales, Jenaro [1 ]
Blanco-Ancos, Luis M. [1 ]
Gil-Prieto, Ruth [2 ]
机构
[1] Madrid Reg Hlth Author, Subdirectorate Hlth Promot & Prevent, C San Martin de Porres 6, Madrid 28035, Spain
[2] Rey Juan Carlos Univ, Area Prevent Med & Publ Hlth, Madrid 28922, Spain
关键词
Chronic conditions; Comorbidity; Epidemiology; Herpes zoster; Hospitalization; Immunosuppression; Incidence; CHRONIC MEDICAL CONDITIONS; POSTHERPETIC NEURALGIA; RISK-FACTORS; VARICELLA; EPIDEMIOLOGY; BURDEN; IMPACT; INFECTION; DECLINE; EUROPE;
D O I
10.1016/j.jinf.2015.10.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: This study aimed to estimate the frequency of hospitalizations due to herpes zoster (HZ) and to describe their clinical characteristics by sex and age group. Methods: Descriptive population-based cross-sectional study of hospital admissions due to HZ from 2003 to 2013 among residents in the Autonomous Community of Madrid. Sex, age, comorbidities, length of stay and outcomes were collected and described. Crude and age-adjusted cumulative incidence rates, and stratified by sex and age, were estimated. Robust Poisson regression analysis was used to calculate the incidence rate ratios by age group. Results: 2039 hospitalizations were identified (51.0% in women). Complicated HZ caused 48.7% of them (50.9% in women). The hospitalization rate was 2.98/100,000 person-years and 7.19/1000 cases of HZ in primary care. Both rates were significantly higher in men, except in the extreme age groups. An immunosuppression-associated comorbidity was identified in 32.8% of the cases and was less common in patients >= 75 years of age. The median length of stay was 6 days, and in-hospital mortality was 1.4%. Conclusions: Hospitalization rates due to HZ were higher in men and increased with age. In two out of every three cases, a comorbidity that potentially caused immunosuppression could not be identified. These cases could benefit from vaccination. (C) 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:70 / 79
页数:10
相关论文
共 50 条
  • [1] HERPES ZOSTER-ASSOCIATED NEURALGIA
    TERBORG, C
    BUSSE, O
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (19) : 700 - 700
  • [2] Herpes Zoster-Associated Abdominal Pseudohernia
    Tan, Sandra M. Y.
    Sek, Kathleen S. Y.
    Teng, Gim Gee
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (02): : E119 - E120
  • [3] REDUCED HERPES ZOSTER-ASSOCIATED HEALTHCARE UTILIZATION IN ADULTS VACCINATED WITH SHINGLES VACCINE
    Smith, N.
    Tseng, H. F.
    Jacobsen, S. J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S23 - S23
  • [4] Herpes zoster-associated paresis of the left arm
    Ludriksone, L.
    Tittelbach, J.
    Elsner, P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (06) : 705 - 706
  • [5] Herpes zoster-associated trigeminal neurotrophic ulcer
    Nielsen, NH
    Petersen, CS
    ACTA DERMATO-VENEREOLOGICA, 1996, 76 (02) : 159 - 160
  • [6] HYPOTHESES ON THE PATHOGENESIS OF HERPES ZOSTER-ASSOCIATED PAIN
    BENNETT, GJ
    ANNALS OF NEUROLOGY, 1994, 35 : S38 - S41
  • [7] Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003-2013
    Esteban-Vasallo, Maria D.
    Felicitas Dominguez-Berjon, M.
    Gil-Prieto, Ruth
    Astray-Mochales, Jenaro
    Gil de Miguel, Angel
    JOURNAL OF INFECTION, 2015, 71 (01) : 85 - 92
  • [8] HERPES ZOSTER-ASSOCIATED MENINGOENCEPHALITIS IN PATIENTS WITH SYSTEMIC CANCER
    HUGHES, BA
    KIMMEL, DW
    AKSAMIT, AJ
    MAYO CLINIC PROCEEDINGS, 1993, 68 (07) : 652 - 655
  • [9] Herpes zoster-associated mortality in Europe: a systematic review
    Bricout, Helene
    Haugh, Margaret
    Olatunde, Olugbenga
    Gil Prieto, Ruth
    BMC PUBLIC HEALTH, 2015, 15
  • [10] Herpes zoster-associated mortality in Europe: a systematic review
    Hélène Bricout
    Margaret Haugh
    Olugbenga Olatunde
    Ruth Gil Prieto
    BMC Public Health, 15